Registration of securities issued in business combination transactions

Condensed Statements of Cash Flows (Unaudited)

v3.22.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended
Mar. 31, 2021
Sep. 30, 2020
Dec. 31, 2020
Sep. 30, 2021
Cash Flows from Operating Activities:        
Net income (loss) $ (1,000) $ (1,000) $ 3,341,073
Adjustments to reconcile net income (loss) to net cash used in operations:        
Net gain on investments held in Trust Account     (1,747)
Change in fair value of warrant liabilities     (4,037,000)
Changes in operating assets and liabilities:        
Prepaid expenses     (583,799)
Accounts payable     75,024
Accrued expenses   1,000   102,370
Accrued offering expense     33,960
Accrued expense – related party     20,000
Franchise tax payable     24,034
Expensed offering costs 1,000 256,379
Net cash used in operating activities (769,706)
Cash Flows from Investing Activities:        
Investment of cash in Trust Account     (174,225,000)
Net cash used in investing activities     (174,225,000)
Cash Flows from Financing Activities:        
Proceeds from promissory note – related party     188,302
Repayment of promissory note – related party     (188,302)
Proceeds from initial public offering, net of underwriter’s discount paid     169,050,000
Proceeds from sale of private placement warrants     7,175,000
Payment of offering costs     (466,282)
Proceeds from sale of Founder Shares   25,000  
Proceeds from sale of Common stock to Sponsor   25,000  
Net cash provided by financing activities 25,000 25,000 175,758,718
Net Change in Cash 25,000 25,000 764,012
Cash – Beginning of period 25,000 25,000
Cash – End of period 25,000 25,000 25,000 789,012
Supplemental disclosures of non-cash investing and financing activities:        
Initial classification of warrant liabilities     $ 16,707,500
Non-cash investing and financing activities:        
Deferred offering costs included in accrued offering costs $ 128,165